Literature DB >> 8574982

Sebaceous carcinoma of the eyelid in an immunocompromised patient with Muir-Torre syndrome.

F A Stockl1, A M Dolmetsch, F Codère, M N Burnier.   

Abstract

Entities:  

Mesh:

Year:  1995        PMID: 8574982

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


× No keyword cloud information.
  6 in total

1.  Skin cancers associated with HIV infection and solid-organ transplantation among elderly adults.

Authors:  Emilie Lanoy; Dominique Costagliola; Eric A Engels
Journal:  Int J Cancer       Date:  2010-04-01       Impact factor: 7.396

2.  Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States.

Authors:  Emilie Lanoy; Graça M Dores; Margaret M Madeleine; Jorge R Toro; Joseph F Fraumeni; Eric A Engels
Journal:  AIDS       Date:  2009-01-28       Impact factor: 4.177

3.  Sebaceous Cell Carcinoma of the Lower Eyelid in an Elderly Male: a Rare Case Report and Review of Literature.

Authors:  Sachin S Kadam; Tejaswini Kadam; Vishwanath Jigjinni; Sanjay M H
Journal:  Indian J Surg Oncol       Date:  2021-03-23

Review 4.  Updates on the clinical diagnosis and management of ocular sebaceous carcinoma: a brief review of the literature.

Authors:  Yangfan Xu; Fang Li; Renbing Jia; Xianqun Fan
Journal:  Onco Targets Ther       Date:  2018-06-27       Impact factor: 4.147

5.  Left Buttock Sebaceus Carcinoma: A Case Report and Review of the Literature.

Authors:  Răzvan Mercuţ; Mihaela Ionescu; Cristiana Simionescu; Vlad Pîrvănescu; Maria Filoftea Mercuţ; Alexandru Gogănău; Marius Eugen Ciurea
Journal:  Curr Health Sci J       Date:  2021-12-31

Review 6.  Muir-Torre Syndrome Associated Periocular Sebaceous Neoplasms: Screening Patterns in the Literature and in Clinical Practice.

Authors:  Maya Eiger-Moscovich; Ralph C Eagle; Carol L Shields; Hilary Racher; Sara E Lally; Rona Z Silkiss; Jerry A Shields; Tatyana Milman
Journal:  Ocul Oncol Pathol       Date:  2020-01-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.